Barger et al. have shown that the mechanism underlying TERT reactivation in glioblastomas and urothelial bladder carcinomas is analogous to that observed in the case of TPM. TERT activation requires the additional ETS binding site provided by a wild-type sequence duplication and also of GABP transcription factor complex [46]. Here, TERT is linked to bladder transitional cell carcinoma.